Our partner is dedicated to developing targeted therapies using protein degradation technology. Their approach aims to address a wide range of diseases, including cancer, by selectively eliminating disease-causing proteins, ultimately improving patient outcomes through precision medicine.

This critical hire led cross-functional teams to develop integrated plans for pre-clinical and early clinical programs, supporting IND filings and Phase I/II studies. With a focus on oncology and clinical product development, the hire collaborated closely with Research and Clinical teams to ensure timely execution of program objectives. The ideal candidate brought expertise in clinical development strategies and a strong understanding of the pharmaceutical industry.